Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

NCT05608148 is registered in ClinicalTrials.gov with Kyushu University as lead sponsor.

NCT NCT05608148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05608148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
Lead sponsor
Kyushu University
Phase
Phase 1
Overall status
Recruiting
Start date
October 26, 2022
Completion date
August 25, 2027
Enrollment
61 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric solid tumors, refractory/relapse neuroblastoma